Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China
Clinical Microbiology and Infection · 2024
DOI: 10.1016/j.cmi.2024.08.016 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Microbiology and Infection, 2024. Verfasst von Pan Fu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiology, Department of Clinical Laboratory, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai,…. Hauptthemen laut MEDLINE: Bordetella pertussis, Whooping Cough, Macrolides, COVID-19. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Chinese Academy of Sciences, Shanghai Rising-Star Program.
Abstract (Originalsprache)
OBJECTIVES: China has experienced a notable upsurge in pertussis cases post-COVID-19, alongside an age shift to older children, increased vaccine escape, and a notable rise in the prevalence of macrolide-resistant Bordetella pertussis. Here, we present a genomic epidemiological investigation of these events. METHODS: We performed a retrospective observational study using culture-positive B pertussis isolated in Shanghai, China, from 2016 to 2024. We analysed strain and pertussis epidemiology dynamics by integrating whole-genome sequencing of 723 strains with antimicrobial susceptibility, transcriptomic profile, and clinical data. We compared the genome sequences of Shanghai strains with 6450 Chinese and global strains. RESULTS: From pre-COVID-19 (before December 2019) to post-COVID-19, patients shifted from predominantly infants (90%, 397/442) to a higher proportion of infections in older children (infant: 16%, 132/844), with the share of vaccinated individuals surging from 31% (107/340) to 88% (664/756). The macrolide-resistant Bordetella pertussis prevalence increased from 60% (267/447) to 98% (830/845). The emergence and expansion of a ptxP3-lineage macrolide-resistant clone, MR-MT28, which is uniquely capable of causing substantial infections among older children and vaccinated individuals, was temporally strongly associated with the pertussis upsurge and epidemiological transition. Although MR-MT28 showed increased expression of genes encoding pertussis toxin, it was associated with significantly milder clinical symptoms and a lower hospitalization rate. MR-MT28 likely originated in China around 2016, after acquiring several key mutations, including a novel prn150 allele, and has been detected across multiple regions in China. In addition, 26% (50/195) of MR-MT28 has evolved into predicted Pertactin (PRN)-deficient strains, with an IS481 insertion being the predominant mechanism. DISCUSSION: We report that the post-COVID-19 upsurge of pertussis in China is associated with ptxP3-MR-MT28, and provide evidence that pathogen evolution is likely the primary factor driving + pertussis upsurge, age shift, and vaccine escape. MR-MT28 poses a high risk of global spread and warrants global surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Microbiology, Department of Clinical Laboratory, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China; Nosocomial Infection Control Department, Children's Hospital o…
- Pediatric Intensive Care Unit, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
- Laboratory of Microbiology, Department of Clinical Laboratory, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
- The Center for Microbes, Development and Health, Chinese Academy of Sciences (CAS) Key Laboratory of Molecular Virology and Immunology, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai…
- Department of Bacteriology, Capital Institute of Pediatrics, Beijing, China.
- Microbiology Laboratory, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
Förderung
- National Key Research and Development Program of China
- Chinese Academy of Sciences
- Shanghai Rising-Star Program
- National Natural Science Foundation of China
- Youth Innovation Promotion Association
- Chinese Academy of Sciences Youth Innovation Promotion Association
Zitieren
APA
Fu, P., Yan, G., Li, Y., Xie, L., Ke, Y., Qiu, S., Wu, S., Shi, X., Qin, J., Zhou, J., Lu, G., Yang, C., & Wang, C. (2024). Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2024.08.016
Vancouver
Fu P, Yan G, Li Y, Xie L, Ke Y, Qiu S, et al. Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China. Clinical Microbiology and Infection. 2024. doi:10.1016/j.cmi.2024.08.016
BibTeX
@article{Fu2024,
author = {Fu, Pan and Yan, Gangfen and Li, Yijia and Xie, Li and Ke, Yuehua and Qiu, Shuxiang and Wu, Shuang and Shi, Xiaolu and Qin, Jie and Zhou, Jinlan and Lu, Guoping and Yang, Chao and Wang, Chuanqing},
title = {Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China},
journal = {Clinical Microbiology and Infection},
year = {2024},
doi = {10.1016/j.cmi.2024.08.016}
}
EUVIMED